Amryt Pharma Plc ADR (AMYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 61,126 | 68,536 | 59,129 | 54,830 | 56,519 |
| Cost of Goods | 33,703 | 33,364 | 30,775 | 29,186 | 27,265 |
| Gross Profit | 27,423 | 35,172 | 28,354 | 25,644 | 29,254 |
| Operating Expenses | 38,595 | 42,412 | 41,915 | 43,722 | 50,886 |
| Operating Income | -10,469 | -6,876 | -12,786 | -17,892 | -21,367 |
| Other Income | -7,631 | -73 | -12,236 | 66,601 | -11,369 |
| Pre-tax Income | -18,100 | -6,949 | -25,022 | 48,709 | -32,736 |
| Income Tax | 2,695 | 100 | -10,531 | 7,164 | -15,527 |
| Net Income Continuous | -20,795 | -7,049 | -14,491 | 41,545 | -17,209 |
| Net Income | $-20,795 | $-7,049 | $-14,491 | $41,545 | $-17,209 |
| EPS Basic Total Ops | -0.30 | -0.10 | -0.25 | 1.00 | -0.35 |
| EPS Basic Continuous Ops | -0.32 | -0.11 | -0.23 | 1.00 | -0.33 |
| EPS Diluted Total Ops | -0.30 | -0.10 | -0.25 | 1.00 | -0.35 |
| EPS Diluted Continuous Ops | -0.32 | -0.11 | -0.23 | 1.00 | -0.33 |
| EPS Diluted Before Non-Recurring Items | -0.06 | -0.02 | -0.05 | 0.15 | -0.07 |
| EBITDA(a) | $9,582 | $10,206 | $3,603 | $391 | $-7,773 |